|
[18F]-FAPI-74 Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 2: 1Phase 2/3: 1
Top Sponsors
- National Cancer Institute (NCI)1
- Leiden University Medical Center1
Indications
- Gastric Cancer2
- Cancer2
- Liver Disease1
- Pheochromocytoma/Paraganglioma (PPGL)1
- Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)1
Other1 trial
Bethesda, Maryland1 trial
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Institutes of Health Clinical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.